The Breast DCIS Score test provides an individualized assessment for the risk of local recurrence. Performed on a tumor sample after a biopsy or surgery, the test looks at 12 cancer-related genes in your patient’s tumor—giving you information that clinical and pathologic factors alone can’t provide. In fact, the test shows that patients with similar clinical and pathologic features do not necessarily have the same local recurrence risk.2-4
The Breast DCIS Score test results include 2-4:
- An individualized prediction of the 10-year risk of any local recurrence (DCIS or invasive carcinoma) or an invasive local recurrence.
- An established baseline for consideration of absolute benefit from radiation therapy (XRT).
- Quantitative ER and PR single gene expression values.
- A patient-friendly summary page to help explain the results to your patients
Learn more: Oncotype DX Breast DCIS Score
I employed this test to help determine my risk, and couldn’t recommend it more. To the patient, a DCIS score is given to help assess risk. To the doctor, even more info (such as individual markers) can be released and forwarded to the patient. For example, the below article highlights a number of predictive markers. Oncotype DCIS looks at some of these markers and more.
http://breastcancerbydrruddy.com/?p=668
Thank you Kay. I agree. A low risk score also helped give me more peace of mind in my decision to forego further surgery and radiation treatment (I had a close margin of .1mm after 2 surgeries). Insurance initially denied, but Genomic Health was so great and easy to work with. They offered me a “patient assistance” program and covered the entire $4,000 test! You must qualify by household income being less than a certain amount. After appeal, my insurance later changed their mind and decided it would cover the test. I thought I would have to pay 10%, but Genomic Health honored their 100% patient assistance coverage which they promised. You may have to ask your Dr. to order this test. They take a sample from your pathology specimen so you don’t have to do anything further. It is another piece of the puzzle that helps individualize risk of recurrence. I am grateful for this test!